BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37505752)

  • 1. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal Cancer.
    Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2E1 RsaI and 96-bp insertion genetic polymorphisms associated with risk for colorectal cancer.
    Silva TD; Felipe AV; Pimenta CA; Barão K; Forones NM
    Genet Mol Res; 2012 Sep; 11(3):3138-45. PubMed ID: 23007992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
    Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
    PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
    Zhou GW; Hu J; Li Q
    World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
    Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls.
    Qian J; Song Z; Lv Y; Huang X
    Tumour Biol; 2013 Aug; 34(4):2225-31. PubMed ID: 23636797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.
    Gao CM; Takezaki T; Wu JZ; Chen MB; Liu YT; Ding JH; Sugimura H; Cao J; Hamajima N; Tajima K
    World J Gastroenterol; 2007 Nov; 13(43):5725-30. PubMed ID: 17963298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
    Liu R; Yin LH; Pu YP
    Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CYP2E1 genotypes in susceptibility to colorectal cancer in the Kashmiri population.
    Sameer AS; Nissar S; Qadri Q; Alam S; Baba SM; Siddiqi MA
    Hum Genomics; 2011 Oct; 5(6):530-7. PubMed ID: 22155602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RsaI but not DraI polymorphism in CYP2E1 gene increases the risk of gastrointestinal cancer in Malaysians: a case-control study.
    Chong ET; Lee CC; Chua KH; Chuah JA; Lee PC
    BMJ Open; 2014 Jan; 4(1):e004109. PubMed ID: 24394801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2E1 genetic polymorphism with dietary, tobacco, alcohol habits, H. pylori infection status and susceptibility to stomach cancer in Mizoram, India.
    Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Baruah D; Mahanta J; Narain K
    Asian Pac J Cancer Prev; 2014; 15(20):8815-22. PubMed ID: 25374213
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Fernandes GM; Russo A; Proença MA; Gazola NF; Rodrigues GH; Biselli-Chicote PM; Silva AE; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
    World J Gastroenterol; 2016 Dec; 22(45):9974-9983. PubMed ID: 28018104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians.
    Nishimoto IN; Hanaoka T; Sugimura H; Nagura K; Ihara M; Li XJ; Arai T; Hamada GS; Kowalski LP; Tsugane S
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):675-80. PubMed ID: 10919737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.
    Peng H; Xie SK; Huang MJ; Ren DL
    Tumour Biol; 2013 Aug; 34(4):2389-95. PubMed ID: 23595220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
    Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
    Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphism in cytochrome P450 2E1, salted food and colorectal cancer susceptibility: a case-control study].
    Yu WP; Chen K; Ma XY; Yao KY; Jiang QT; Zou Y; Zhou HG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 May; 38(3):162-6. PubMed ID: 15182482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary and Genetic Biomonitoring of Polycyclic Aromatic Hydrocarbons in Egyptian Coke Oven Workers: Associations between Exposure, Effect, and Carcinogenic Risk Assessment.
    Samir AM; Shaker DA; Fathy MM; Hafez SF; Abdullatif MM; Rashed LA; Alghobary HAF
    Int J Occup Environ Med; 2019 Jul; 10(3):124-136. PubMed ID: 31325295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
    Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.
    Cao L; Lin J; He B; Wang H; Rao J; Liu Y; Zhang X
    Tumour Biol; 2014 Jan; 35(1):455-62. PubMed ID: 23934444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.